Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study
Makaleler > Tam Makale · 2017
Yazarlar: Alessandra Franzetti Pellanda, Berardino De Bari, Elisabeth Deniaud-Alexandre, Marco Krengli, Paul Van Houtte, Antonella Richetti, Salvador Villa, Hadassah Goldberg, Ewa Szutowicz-Zielinska, Michel Bolla, Heidi Rutten, Marc Van Eijkeren, Philip Poortmans, Guido Henke, Yavuz ANACAK, Steve Chan, Christine Landmann, Carine Kirkove, Luciano Scandolaro, Jacques Bernier, Rene-Olivier Mirimanoff, Mahmut Ozsahin
CHINESE JOURNAL OF CANCER RESEARCH, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2017, cilt 29, ss 521-532
DOI: 10.21147/j.issn.1000-9604.2017.06.06
Özet
Objective: Primary uterine leiomyosarcomas (ULMS) are rare, and the optimal treatment is controversial. We aimed to assess the outcome and prognostic factors in a multicenter population of women treated for primary ULMS.